-
Efficacy of exercise-based cardiac rehabilitation post–myocardial infarction: A systematic review and meta-analysis of randomized controlled trials
October 2011 (Vol. 162 | No. 4 | Pages 571-584.e2)
Patrick R. Lawler, Kristian B. Filion, Mark J. Eisenberg
-
Rationale and design of RE-LY: Randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran
May 2009 (Vol. 157 | No. 5 | Pages 805-810.e2)
Michael D. Ezekowitz, Stuart Connolly, Amit Parekh, Paul A. Reilly, Jeanne Varrone, Susan Wang, Jonas Oldgren, Ellison Themeles, Lars Wallentin, Salim Yusuf
-
Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease
November 2010 (Vol. 160 | No. 5 | Pages 785-794.e10)
SHARP Collaborative Group
-
Rationale and design of the Anti-Xa Therapy to Lower cardiovascular events in Addition to standard therapy in Subjects with Acute Coronary Syndrome–Thrombolysis in Myocardial Infarction 51 (ATLAS-ACS 2 TIMI 51) trial: A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rivaroxaban in subjects with acute coronary syndrome
May 2011 (Vol. 161 | No. 5 | Pages 815-821.e6)
C. Michael Gibson, Jessica L. Mega, Paul Burton, Shinya Goto, Freek Verheugt, Christoph Bode, Alexei Plotnikov, Xiang Sun, Nancy Cook-Bruns, Eugene Braunwald
-
Newest-generation drug-eluting and bare-metal stents combined with prasugrel-based antiplatelet therapy in large coronary arteries: The BAsel Stent Kosten Effektivitäts Trial PROspective Validation Examination part II (BASKET-PROVE II) trial design
February 2012 (Vol. 163 | No. 2 | Pages 136-141.e1)
Raban Jeger, Matthias Pfisterer, Hannes Alber, Franz Eberli, Søren Galatius, Christoph Naber, Giovanni Pedrazzini, Hans Rickli, Jan Skov Jensen, André Vuilliomenet, Nicole Gilgen, Christoph Kaiser
